| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ANETT: PhAse II trial of NEoadjuvant TAK-228 plus Tamoxifen in patients with hormone receptor-positive breast cancer
|
Koca, Emre
|
|
|
188 |
2 |
p. 433-439
|
artikel
|
| 2 |
A phase I trial of sorafenib with whole brain radiotherapy (WBRT) in breast cancer patients with brain metastases and a correlative study of FLT-PET brain imaging
|
Morikawa, Aki
|
|
|
188 |
2 |
p. 415-425
|
artikel
|
| 3 |
Breast cancer treatment and survival differences in women in remote and socioeconomically disadvantaged areas, as demonstrated by linked data from New South Wales (NSW), Australia
|
Buckley, Elizabeth
|
|
|
188 |
2 |
p. 547-560
|
artikel
|
| 4 |
Comparison of two targeted ultra-deep sequencing technologies for analysis of plasma circulating tumour DNA in endocrine-therapy-resistant breast cancer patients
|
Nteliopoulos, Georgios
|
|
|
188 |
2 |
p. 465-476
|
artikel
|
| 5 |
Congruence and trajectories of device-measured and self-reported physical activity during therapy for early breast cancer
|
Helbrich, H.
|
|
|
188 |
2 |
p. 351-359
|
artikel
|
| 6 |
Cutaneous toxicities occurring during palbociclib (CDK4/6 inhibitor) and endocrine therapy in patients with advanced breast cancer: a single-centre experience
|
Chawla, Sumir
|
|
|
188 |
2 |
p. 535-545
|
artikel
|
| 7 |
Developing patient-centred strategies to optimize the management of vasomotor symptoms in breast cancer patients: a survey of health care providers
|
Cole, Katherine Marie
|
|
|
188 |
2 |
p. 343-350
|
artikel
|
| 8 |
Effects of local laser treatment on vulvovaginal atrophy among women with breast cancer: a prospective study with long-term follow-up
|
Veron, Lucie
|
|
|
188 |
2 |
p. 501-509
|
artikel
|
| 9 |
Exercise and health-related fitness predictors of chemotherapy completion in breast cancer patients: pooled analysis of two multicenter trials
|
An, Ki-Yong
|
|
|
188 |
2 |
p. 399-407
|
artikel
|
| 10 |
Final overall survival analysis of the phase 3 HERITAGE study demonstrates equivalence of trastuzumab-dkst to trastuzumab in HER2-positive metastatic breast cancer
|
Rugo, Hope S.
|
|
|
188 |
2 |
p. 369-377
|
artikel
|
| 11 |
Long-term follow-up results of fluorescence and blue dye guided sentinel lymph node biopsy in early breast cancer
|
Wang, Chaobin
|
|
|
188 |
2 |
p. 361-368
|
artikel
|
| 12 |
Long-term PM2.5 exposure before diagnosis is associated with worse outcome in breast cancer
|
Prada, Diddier
|
|
|
188 |
2 |
p. 525-533
|
artikel
|
| 13 |
Management and outcomes of men diagnosed with primary breast cancer
|
Johnson, Andrew E.
|
|
|
188 |
2 |
p. 561-569
|
artikel
|
| 14 |
Mastectomy alone for pT1-2 pN0-1 breast cancer patients: when postmastectomy radiotherapy is indicated
|
Leonardi, Maria Cristina
|
|
|
188 |
2 |
p. 511-524
|
artikel
|
| 15 |
Neratinib + capecitabine sustains health-related quality of life in patients with HER2-positive metastatic breast cancer and ≥ 2 prior HER2-directed regimens
|
Moy, Beverly
|
|
|
188 |
2 |
p. 449-458
|
artikel
|
| 16 |
Phase II study of propranolol feasibility with neoadjuvant chemotherapy in patients with newly diagnosed breast cancer
|
Hopson, Madeleine B.
|
|
|
188 |
2 |
p. 427-432
|
artikel
|
| 17 |
Pre-diagnosis major life stressors and breast cancer outcomes
|
Pai, Tanmayi
|
|
|
188 |
2 |
p. 459-464
|
artikel
|
| 18 |
Prognosis of breast cancer diagnosed during pregnancy and early postpartum according to immunohistochemical subtype: A matched case–control study
|
Muñoz-Montaño, Wendy R.
|
|
|
188 |
2 |
p. 489-500
|
artikel
|
| 19 |
Randomized Phase II Trial of Capecitabine and Lapatinib with or without IMC-A12 (Cituxumumab) in Patients with HER2-Positive Advanced Breast Cancer Previously Treated with Trastuzumab and Chemotherapy: NCCTG N0733 (Alliance)
|
Haddad, Tufia C.
|
|
|
188 |
2 |
p. 477-487
|
artikel
|
| 20 |
Safety and efficacy study of oral metronomic vinorelbine combined with trastuzumab (mNH) in HER2-positive metastatic breast cancer: a phase II trial
|
Wang, Zijing
|
|
|
188 |
2 |
p. 441-447
|
artikel
|
| 21 |
Salvage of locally recurrent breast cancer with repeat breast conservation using 45 Gy hyperfractionated partial breast re-irradiation
|
Chen, Ishita
|
|
|
188 |
2 |
p. 409-414
|
artikel
|
| 22 |
Survival before and after the introduction of pertuzumab and T-DM1 in HER2-positive advanced breast cancer, a study of the SONABRE Registry
|
Ibragimova, Khava I. E.
|
|
|
188 |
2 |
p. 571-581
|
artikel
|
| 23 |
Taxane versus vinorelbine in combination with trastuzumab and pertuzumab for first-line treatment of metastatic HER2-positive breast cancer: a retrospective two-center study
|
Reinhorn, Daniel
|
|
|
188 |
2 |
p. 379-387
|
artikel
|
| 24 |
The difference in local, regional and distant breast cancer recurrence between the immediate and delayed DIEP flap procedure; a retrospective cohort study
|
Joosen, M. E. M.
|
|
|
188 |
2 |
p. 389-398
|
artikel
|
| 25 |
ZEB1 directly inhibits GPX4 transcription contributing to ROS accumulation in breast cancer cells
|
Han, Xiao
|
|
|
188 |
2 |
p. 329-342
|
artikel
|
Tijdschrift beschrijving